Mitophagy in Neurodegenerative Diseases: Mechanisms of Action and the Advances of Drug Discovery
Panpan Yang,
No information about this author
Shuai Wen,
No information about this author
Xin Wang
No information about this author
et al.
Journal of Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 5, 2025
Neurodegenerative
diseases
(NDDs),
such
as
Parkinson's
disease
(PD)
and
Alzheimer's
(AD),
are
devastating
brain
incurable
at
the
moment.
Increasing
evidence
indicates
that
NDDs
associated
with
mitochondrial
dysfunction.
Mitophagy
removes
defective
or
redundant
mitochondria
to
maintain
cell
homeostasis,
whereas
deficient
mitophagy
accelerates
accumulation
of
damaged
mediate
pathologies
NDDs.
Therefore,
targeting
has
become
a
valuable
therapeutic
pathway
for
treatment
Several
modulators
have
been
shown
ameliorate
neurodegeneration
in
PD
AD.
However,
it
remains
be
further
investigated
other
Here,
we
describe
mechanism
key
signaling
summarize
roles
on
pathogenesis
Further,
underline
development
advances
AD
therapy,
discuss
challenges
limitations
existing
modulators,
provide
guidelines
exploration
drug
design.
Language: Английский
Gallic acid alleviates Alzheimer's disease by inhibiting p38/MAPK signaling pathway
Jiaxin Wang,
No information about this author
Qingling Wang,
No information about this author
Xiao Tu
No information about this author
et al.
Journal of Functional Foods,
Journal Year:
2025,
Volume and Issue:
127, P. 106745 - 106745
Published: March 21, 2025
Language: Английский
Tauopathy after long‐term cervical lymphadenectomy
Alzheimer s & Dementia,
Journal Year:
2025,
Volume and Issue:
21(4)
Published: April 1, 2025
Abstract
INTRODUCTION
This
study
examined
the
effects
of
long‐term
cervical
lymphadenectomy
(cLE)
on
cognitive
and
Alzheimer's
disease
(AD)–like
tauopathy
changes.
METHODS
Male
C57BL/6
mice
were
used
to
assess
cLE
impacts
sleep,
brain
pathways,
pathologies.
RNA
sequencing
proteomics
analyzed
gene/protein
changes,
with
results
verified
by
western
blotting
immunofluorescence.
RESULTS
CLE
led
sleep
psychiatric
disorders,
linked
mitogen‐activated
protein
kinase/extracellular
signal‐regulated
kinase
(ERK)
pathway
activation.
Activation
ERK
may
interfere
autophagy
is
associated
phosphorylated
tau
accumulation.
Peripheral
blood
analysis
shows
decreased
waste
in
peripheral
post‐cLE,
implicating
impaired
lymphatic
drainage
build‐up.
DISCUSSION
These
findings
suggest
a
potential
connection
between
AD‐like
tauopathy,
potentially
influencing
surgical
decisions.
Highlights
Cervical
cornerstone
head
neck
cancers,
affecting
millions
people
each
year.
We
provide
first
evidence
mildly
functioning
significant
anxiety–depressive
disorders
after
cLE.
Long‐term
not
only
directly
impairs
wastes
(amyloid
beta,
[p‐tau])
drainage,
but
also
activates
Erk1/2
signaling
leading
attenuation
autophagy.
found
for
time
that
accelerated
deposition
p‐tau
young
mice.
Patients
clinical
lymph
node
dissection
showed
reduced
consistent
mouse
models.
suggests
need
further
evaluation
neurologic
dissection,
procedure
affects
Language: Английский